Hydroxia Esseti Farmaceutici (Glutathione Sodium)

Glutathione sodium supplies the tripeptide glutathione directly to the bloodstream. Once inside cells, glutathione participates in redox reactions, neutralising reactive oxygen species, regenerating other antioxidants, and serving as a co‑factor for detoxifying enzymes that conjugate and eliminate harmful metabolites.

The dosage of Hydroxia Esseti Farmaceutici is determined by the prescribing clinician based on the patient’s condition, weight, renal and hepatic function, and therapeutic goals. Dosing regimens are individualized and should follow the prescriber’s specific instructions.

Safety data for glutathione sodium during pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by the treating physician after a thorough risk‑benefit assessment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed) and the necessary import documentation.

Glutathione sodium directly replenishes intracellular glutathione, whereas agents like N‑acetylcysteine act as precursors that must be converted before increasing glutathione levels. Hydroxia therefore offers a more immediate boost in antioxidant capacity, but clinical choice depends on the specific indication, patient tolerance, and physician preference.

The product must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken vigorously. It should be kept in its original packaging until use to maintain sterility and potency.

Hydroxia Esseti Farmaceutici is administered by a qualified healthcare professional via intramuscular or intravenous injection. The solution is supplied in a sterile vial and should be diluted or used according to the prescriber’s instructions and aseptic technique guidelines.

The most serious adverse events include anaphylactic or severe hypersensitivity reactions, hemolysis in patients with glucose‑6‑phosphate dehydrogenase deficiency, and acute renal failure, particularly with high‑dose or prolonged administration. Immediate medical attention is required if any of these occur.

Patients with a known hypersensitivity to glutathione or any excipients in the formulation, individuals with G6PD deficiency, those with severe renal impairment, and patients who have experienced severe reactions to similar injectable antioxidants should avoid using this product unless a physician determines that benefits outweigh the risks.